Sarah Elderkin

3.0k citations
15 papers · 1.7k indexed · h-index 14

Sarah Elderkin

15 papers receiving 1.7k citations

Peers

Sarah Elderkin
Comparison fields: 5 of 81
  • Molecular Biology 1.5k
  • Cell Biology 239
  • Genetics 392
  • Endocrinology 35
  • Cancer Research 99
Replace Katsura Asano with:
Katsura Asano United States
Scott Lauder United States
Keiko Umezu Japan
Marcin Pacek United States
Christopher J. Shoemaker United States
Simonne Longerich United States
R. Alex Wu United States
Sergey G. Kuznetsov Finland
Matthew C. Whitby United Kingdom
Richard T. Pomerantz United States
Sarah Elderkin relative to Katsura Asano United States Katsura Asano's profile →
Citations per field
00.5×1.5×
Katsura Asano · 1×
Citations per year

Countries citing papers authored by Sarah Elderkin

Since Specialization
Citations

This map shows the geographic impact of Sarah Elderkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Elderkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Elderkin more than expected).

Fields of papers citing papers by Sarah Elderkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Elderkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Elderkin. The network helps show where Sarah Elderkin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sarah Elderkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Elderkin Line = papers co-authored together Sarah Elderkin links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201915
2 201757
3 201643
4 2014251
5 2012433
6 201210
7 2010132
8 200939
9 2007106
10 200554
11 200473
12 200461
13 200293
14 2001113
15 2001188

About Sarah Elderkin

Sarah Elderkin is a scholar working on Molecular Biology, Genetics, Materials Chemistry, Cell Biology and Immunology, having authored 15 papers that have together received 1.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Genomics and Chromatin Dynamics (6 papers), Bacterial Genetics and Biotechnology (3 papers), Enzyme Structure and Function (3 papers), Ubiquitin and proteasome pathways (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related gene regulation (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Cell Biology (239 citations), Genetics (392 citations), Endocrinology (35 citations) and Cancer Research (99 citations). Sarah Elderkin has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Neil Brockdorff, Martin Buck, Susan Jones, Kevin Hiom, Deema Hussein, Stephen S. Taylor, Yunmei Wang, Christopher J. Morrow, Gordon Peters and Goedele N. Maertens. Their work appears in journals such as Genes & Development, Molecular Cell, Cell, The EMBO Journal and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026